在非IPF纤维化间歇性肺病中进展的模式
1Royal Brompton Hospital and Imperial College, London, UK.
Current opinion in pulmonary medicine
|July 7, 2023
概括
在纤维化间歇性肺病 (ILD) 中识别渐进性肺纤维化 (PPF) 模式至关重要. 某些标准,如10%的强迫生命能力 (FVC) 降低,显示出对死亡率的预后意义.
科学领域:
- 肺部病理学 肺部病理学
- 纤维化间歇性肺部疾病研究研究
- 疾病进展的特征 疾病进展的特征
背景情况:
- 纤维化间歇性肺病 (ILD) 包括导致渐进性肺纤维化 (PPF) 的情况.
- 早期识别PPF对于及时干预和改善患者结果至关重要.
- 了解疾病进展模式是完善诊断和预后标准的关键.
研究的目的:
- 描述纤维性ILD患者疾病进展的模式.
- 为了确定不同PPF进展模式的相对患病率.
- 评估这些模式的预后意义,特别是关于死亡率.
主要方法:
- 对大型临床队列的分析,以确定PPF标准.
- 基于患病率,进展时间和症状恶化的标准的评估.
- 使用死亡率数据和强迫生命能力 (FVC) 进展的预后意义的评估.
主要成果:
- 包括10%以上相对FVC下降或FVC下降,症状和成像纤维化进展的组合在内的PPF标准很普遍.
- 这些模式显示出对死亡率的预后意义,尽管对于FVC进展存在相互矛盾的数据.
- 炎症性肌肉病的进展模式在ILD亚组中是相似的,除了炎症性肌肉病患者.
结论:
- INBUILD PPF标准得到了基于患病率和预后意义的早期PPF识别的最新数据的支持.
- 现有的PPF指定多国指南可能与现实世界队列数据不完全一致.
- 需要进一步的研究来验证在各种ILD人群中PPF标准.
相关概念视频
Types of Intermediate Filaments
3.7K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
3.7K
Pulmonary Hypertension: Classification and Pathogenesis
231
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
231
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
COPD: Pathogenesis and Clinical Features
358
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
358
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


